Clinical Trials Logo

Positive Evaluable) clinical trials

View clinical trials related to Positive Evaluable).

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00520936 Completed - Osteosarcoma Clinical Trials

A Study of Pemetrexed in Children With Recurrent Cancer

Start date: September 2007
Phase: Phase 2
Study type: Interventional

To determine the response rate of pemetrexed given every 21 days for the treatment of children with relapsed or refractory osteosarcoma, Ewing's sarcoma/peripheral primitive neuroectodermal tumors (PNET), rhabdomyosarcoma, neuroblastoma, ependymoma, medulloblastoma/supratentorial PNET or non-brain stem high-grade glioma.